What is the address of V-Bio Ventures?

The registered office of V-Bio Ventures is located at Pieter van Reysschootlaan 2 box 104, 9051 Gent.

Is V-Bio Ventures still active?

Yes. According to the CBE (31 October 2026) V-Bio Ventures is active, legal situation “Normale toestand”, started on 18 November 2020.

Is V-Bio Ventures registered on Peppol?

Yes, V-Bio Ventures is registered on the Peppol network with ID 0208:0758544057.

What is the enterprise number of V-Bio Ventures?

The enterprise number of V-Bio Ventures is BE0758544057.

When was V-Bio Ventures founded?

V-Bio Ventures was founded on 18 November 2020.

Is V-Bio Ventures a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 18 November 2020; 5 annual accounts filed, latest fiscal year 2025.

How much profit did V-Bio Ventures make in 2025?

V-Bio Ventures posted a profit after taxes of € 733,934 in financial year 2025.

What is the revenue of V-Bio Ventures?

In its most recent annual accounts (2025), V-Bio Ventures reported revenue of € 2,971,052.

How much does an employee at V-Bio Ventures earn?

The average wage cost per full-time employee at V-Bio Ventures was € 329,400 in 2025: staff costs of € 1.4 million for 4.2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does V-Bio Ventures have?

According to the 2025 annual accounts, V-Bio Ventures has 4.2 full-time equivalents (FTE).

V-Bio Ventures (Private Limited) - Gent - BE0758544057

Q: What does V-Bio Ventures do?

V-Bio Ventures is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies. Private Limited, started on 18 November 2020, 1 establishment.

Dossier V-Bio Ventures, printed on 31 October 2026 from databakkes.be/en/0758544057/v-bio-ventures. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Busy address KBO

13 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

V-Bio Ventures from Gent, company number BE0758544057, closed financial year 2025 with a result of € 733,934 after tax. For that financial year V-Bio Ventures recorded revenue of € 3 million and equity of € 1.7 million. Compared with financial year 2024, the result moved from € 911,170 to € 733,934. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 1, 2026.

What it is worth Growing

€ 1.7 million

▲ 29% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 733,934

▼ 19% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 2.5 million

▲ 95% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 360,000 paid out

49 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

4.2

▼ 0.5 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 1.4 million

▲ 21% vs 2024

€ 329,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 77

▼ 92% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 36,505

▼ 13% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 197,406

▲ 25% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 3,198,599 Revenue 2022: € 3,198,599 First fiscal year in the series	€ 2,930,648 Revenue 2023: € 2,930,648 ▼ 8% vs 2022 (€ 3,198,599) Unfavourable step	€ 2,910,389 Revenue 2024: € 2,910,389 ▼ 1% vs 2023 (€ 2,930,648) Unfavourable step	€ 2,971,052 Revenue 2025: € 2,971,052 ▲ 2% vs 2024 (€ 2,910,389) Favourable step	▲ 2%
Gross margin	€ 2,675,203 Gross margin 2022: € 2,675,203 First fiscal year in the series	€ 2,375,976 Gross margin 2023: € 2,375,976 ▼ 11% vs 2022 (€ 2,675,203) Unfavourable step	€ 2,350,295 Gross margin 2024: € 2,350,295 ▼ 1% vs 2023 (€ 2,375,976) Unfavourable step	€ 2,362,136 Gross margin 2025: € 2,362,136 ▲ 1% vs 2024 (€ 2,350,295) Favourable step	▲ 1%
Profit after taxes	€ 1,255,105 Profit after taxes 2022: € 1,255,105 First fiscal year in the series	€ 859,094 Profit after taxes 2023: € 859,094 ▼ 32% vs 2022 (€ 1,255,105) Unfavourable step	€ 911,170 Profit after taxes 2024: € 911,170 ▲ 6% vs 2023 (€ 859,094) Favourable step	€ 733,934 Profit after taxes 2025: € 733,934 ▼ 19% vs 2024 (€ 911,170) Unfavourable step	▼ 19%
Equity	€ 758,342 Equity 2022: € 758,342 First fiscal year in the series	€ 806,870 Equity 2023: € 806,870 ▲ 6% vs 2022 (€ 758,342) Favourable step	€ 1,289,449 Equity 2024: € 1,289,449 ▲ 60% vs 2023 (€ 806,870) Favourable step	€ 1,663,383 Equity 2025: € 1,663,383 ▲ 29% vs 2024 (€ 1,289,449) Favourable step	▲ 29%
Total debts	€ 1,642,567 Total debts 2022: € 1,642,567 First fiscal year in the series	€ 1,235,114 Total debts 2023: € 1,235,114 ▼ 25% vs 2022 (€ 1,642,567) Favourable step	€ 560,849 Total debts 2024: € 560,849 ▼ 55% vs 2023 (€ 1,235,114) Favourable step	€ 927,688 Total debts 2025: € 927,688 ▲ 65% vs 2024 (€ 560,849) Unfavourable step	▲ 65%
Cash	€ 2,304,030 Cash 2022: € 2,304,030 First fiscal year in the series	€ 1,987,428 Cash 2023: € 1,987,428 ▼ 14% vs 2022 (€ 2,304,030) Unfavourable step	€ 1,273,913 Cash 2024: € 1,273,913 ▼ 36% vs 2023 (€ 1,987,428) Unfavourable step	€ 2,478,075 Cash 2025: € 2,478,075 ▲ 95% vs 2024 (€ 1,273,913) Favourable step	▲ 95%
Retained profit	€ 728,342 Retained profit 2022: € 728,342 First fiscal year in the series	€ 776,870 Retained profit 2023: € 776,870 ▲ 7% vs 2022 (€ 728,342) Favourable step	€ 1,259,449 Retained profit 2024: € 1,259,449 ▲ 62% vs 2023 (€ 776,870) Favourable step	€ 1,633,383 Retained profit 2025: € 1,633,383 ▲ 30% vs 2024 (€ 1,259,449) Favourable step	▲ 30%
Dividend	€ 990,000 Dividend 2022: € 990,000 First fiscal year in the series	€ 750,000 Dividend 2023: € 750,000 ▼ 24% vs 2022 (€ 990,000) Unchanged	€ 360,000 Dividend 2024: € 360,000 ▼ 52% vs 2023 (€ 750,000) Unchanged	€ 360,000 Dividend 2025: € 360,000 Unchanged (€ 360,000) Unchanged
Balance sheet total	€ 2,400,909 Balance sheet total 2022: € 2,400,909 First fiscal year in the series	€ 2,041,984 Balance sheet total 2023: € 2,041,984 ▼ 15% vs 2022 (€ 2,400,909) Unchanged	€ 1,850,298 Balance sheet total 2024: € 1,850,298 ▼ 9% vs 2023 (€ 2,041,984) Unchanged	€ 2,591,071 Balance sheet total 2025: € 2,591,071 ▲ 40% vs 2024 (€ 1,850,298) Unchanged	▲ 40%
Employees (FTE)	4.7 Employees (FTE) 2022: 4.7 First fiscal year in the series	4.6 Employees (FTE) 2023: 4.6 ▼ 0.1 vs 2022 (4.7) Unchanged	4.7 Employees (FTE) 2024: 4.7 ▲ 0.1 vs 2023 (4.6) Unchanged	4.2 Employees (FTE) 2025: 4.2 ▼ 0.5 vs 2024 (4.7) Unchanged	▼ 0.5

Key figures of V-Bio Ventures, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to V-Bio Ventures?

What happened at V-Bio Ventures in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 1, 2026 New annual accounts for financial year 2025: profit of € 733,934 (▼ 19% vs 2024). Source: NBB ↗
Nov 18, 2020 New establishment in Gent. KBO
Nov 18, 2020 Start of the company according to the CBE. KBO

In short

From € 1.3 million profit in 2022 to € 733,934 profit in 2025.

Paid € 1.3 million in corporate taxes since 2022.

Best year ever: 2022, with € 1.3 million profit.

On average € 562,400 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Pieter van Reysschootlaan 2 box 104

9051 Gent

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 13 companies are registered at this address.

All companies at this address →

CD-Vastgoed

€ 437,585 gross margin · 2025

V-BIO PARTNERS 1

€ -2,244 gross margin · 2025

V-BIO MANAGEMENT 1

€ 822,886 revenue · 2025

V-Bio Fund 1

€ -903,749 gross margin · 2025

V-Bio Co-Invest 1-1

€ -16,692 gross margin · 2025

+8 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0758.544.057

VAT number

BE 0758.544.057

Registered office

Pieter van Reysschootlaan 2 bus 104, 9051 Gent

Names & denominations

V-Bio Ventures

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

18 November 2020

Peppol

Active · Active since 19 Nov 2025

Contact

v-bio.ventures [email protected]

Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige zakelijke dienstverlening, neg

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗